Top Markets
#1 ADO Protocol ADO Protocol +329.10%
#2 GoPlus Security GoPlus Security +53.44%
#3 Nockchain Nockchain +43.26%
#4 Starpower Starpower +34.71%
#5 Tutorial Tutorial +34.36%
#6 The Black Bull The Black Bull +33.14%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +32.41%
#8 GAIB AID GAIB AID +24.67%
#9 Verus Coin Verus Coin +20.40%
#10 Fake World Assets Fake World Assets +18.95%
Coin of the day
ADO Protocol ADO Protocol
Innstillinger
Språk
NORSK
Valuta
USD
Tema
China Regenerative Medicine International Limited China Regenerative Medicine International Limited

China Regenerative Medicine International Limited

8158
Rangering i aksjer #32812
China Regenerative Medicine International Limited operates as an investment... China Regenerative Medicine International Limited operates as an investment holding entity, focusing on the development and distribution of a diverse portfolio of healthcare products and associated services. The company provides extensive health management solutions, covering health condition assessments, detoxification programs, fostering internal bodily balance, nourishing vital organs, and enhancing the immune system. Additionally, its beauty offerings encompass non-surgical medical aesthetics, essential dermatological care, anti-aging skin remedies, hair revitalization, skin firming treatments, localized body contouring, and intimate restoration services. Established in 1995, the organization was previously known as China Bio-Med Regeneration Technology Limited until its rebranding to China Regenerative Medicine International Limited in March 2015. Its headquarters are situated in Tsim Sha Tsui, Hong Kong.
Aksjekurs
$0.02967889
Sist synkronisert: 2026-08-12
Markedsverdi
$9.03M
Endring (1 dag)
0.00%
Endring (1 år)
-72.68%
Land
HK
Handel China Regenerative Medicine International Limited (8158)

Kategori

Healthcare
Inntekter for China Regenerative Medicine International Limited (8158)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til China Regenerative Medicine International Limited er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for China Regenerative Medicine International Limited fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE